Filing Flows

Filing Flows › aTYR Pharma (ATYR) › Next earnings date

aTYR Pharma (ATYR) earnings: missed the estimate

aTYR Pharma (ATYR) reported on Nov 5, 2026 and missed the EPS estimate: −$7.43 against −$4.00 (-85.8%). It beat the EPS estimate in 60% of the quarters on record.

Last result−85.8% vs estimate
Beat rate60%

The last report

aTYR Pharma reported revenue of $190K for the third quarter 2025, net loss $25.7M. How it makes money → · Every quarter →

aTYR Pharma: EPS against the estimate, last 5 reportsaTYR Pharma: EPS against the estimate, last 5 reportsEstimateReported−$7.38−$10.40Nov 25−$7.00−$5.60Mar 26−$5.50−$4.40May 26−$5.00−$4.40Aug 26−$4.00−$7.43Nov 26
Latest (Nov 26): Estimate −$4.00, Reported −$7.43.

aTYR Pharma's latest quarter

aTYR Pharma, Q3 2025: revenue $190K, net loss $25.7M, operating cash flow −$20.5M. The chart follows the revenue to costs, profit and cash.

Questions

Did aTYR Pharma beat earnings?

aTYR Pharma (ATYR) reported on Nov 5, 2026 and missed the EPS estimate: −$7.43 against −$4.00 (-85.8%).

When does ATYR report earnings?

The next date is not set yet.

Does aTYR Pharma usually beat earnings?

It beat the consensus EPS estimate in 60% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.